as the main provider of hepatitis C medicine for patients covered through
CVS Health Corp., intensifying a rivalry to treat patients with pills that
cost $1,000 or more a day.
Gilead’s Harvoni and Sovaldi will be the exclusive drugs for CVS’s standard commercial list of covered medicine, as well as its list for health-care exchanges, Medicare Part D and Medicaid, the benefits manager said today in an e-mail.